IHP final logo Green

By IHP, Nov 4 2016 05:47PM

Much-needed medicines are being shipped to IHP partners, International Medical Corps (IMC), in Haiti this week. They include a range of antibiotics, painkillers, anti-inflammatories, drugs for stomach ulcers, skin conditions and medical supplies.

“IHP is proud to be working in partnership with IMC as part of the emergency response in Haiti” said Louise Hart, IHP’s Associate Director of Health Programmes. “The needs are overwhelming and large numbers of people are without access to basic healthcare services and vital supplies, affecting their ability to recover from the disaster” she continued.

The medicines and supplies are going to the most affected areas of Haiti, Grand’Anse Department, where

43% of health facilities were severely damaged last month by Hurricane Matthew, and Sud Department where 28% of health facilities were damaged.

Cholera continues to be a major concern throughout the country, particularly in the south. According to the UN one million people are expected to need cholera vaccinations in the most affected areas. More than 3,500 suspected cholera cases were reported in October alone.

A one week mass vaccination programme in Grand’Anse and Sud will start on 8 November targeting 900,000 people.

Facts and Figures

• Hurricane Matthew struck Haiti on 4 October

• So far 546 people have died and 128 missing

• 2.1 million people are affected

• 1.4 million people need assistance

• 806,000 people need food urgently

• 140,000+ people are displaced


By IHP, Oct 31 2016 02:33PM

IHP’s partners in northern Iraq are supporting the early humanitarian response for a potentially massive displacement of people as the battle to retake Mosul intensifies.

The offensive began on 17 October. Up to 1.5 million people in Mosul and the surrounding areas face serious danger from cross fire, being used as human shields and sniper attacks as the battle against ISIS by Iraqi troops and their allies, gains momentum.

The UN Environment Programme (UNEP) has reported that civilians are suffering from near suffocation and respiratory illnesses as 19 oil wells have reportedly been set ablaze by retreating ISIS militants.

Lise Grande, the UN humanitarian coordinator for Iraq, said recently, "The UN estimates that in a worst case scenario, Mosul could represent the single largest most complex humanitarian operation in the world in 2016."

What IHP is doing

The UN anticipates an influx of 200,000 displaced people over the coming days and weeks into camps that are already over-stretched. More than 10,000 people have been displaced since the offensive began. IHP is present in these camps, through local partners, supplying the highest quality essential medicines for those in need. We are also provisioning mobile health clinics and government hospitals with medical aid that enables them to deliver frontline health services to vulnerable men, women and children.

How you can help

Give - we are seeking to raise funds to help us reach a further 300,000 people in the region over the next six months. For more information please click here

Donate product - in order to meet the ongoing needs of our Middle East programmes, we seek planned donations of a broad range of medical products. The needs list can be accessed here.

Facts and Figures

• Over three million people have been displaced within Iraq since January 2014

• 800,000 have fled to Iraq’s Kurdish region

• Mosul is Iraq’s second largest city with a population of two million. It was captured by ISIS in June 2014.

• Half a million people fled Mosul after its capture

• 10,548 people have been displaced since the current offensive began on 17 October

• A further 200,000 people are expected to be displaced in the coming weeks


By IHP, Oct 14 2016 09:58AM

Our team met mums in Liberia recently who are living proof that medicines literally save lives. With emotion in her voice, Kimberlyn explained that without IHP’s help she wouldn’t be here today and her daughter Bennett would be growing up without a mother. Maternal death rates - often from acute blood loss or sepsis - have been as high as 1 in 8 over recent years. Supplies are now reaching clinics and hospitals across the country and these statistics are becoming a thing of the past.

At one hospital we met a team of midwives who enthusiastically explained what this ‘Rolls Royce’ of medication can achieve as they proudly introduced us to women enjoying their first few hours of motherhood. Whether speaking to the staff, the mothers or indeed the Minister of Health, the message to IHP and our partners was clear - thank you for saving lives!

Kimberlyn and daughter Bennett
Kimberlyn and daughter Bennett

By IHP, Oct 13 2016 03:25PM

When the mother of four-year-old Malek Harara discovered dark spots and blemishes on his neck and back, she acted fast. She took him to Shejaiya’s only clinic run by where local mothers get up early to wait in line with their children. The clinic is run by IHP partner, ANERA.

The dermatologist, Dr. Rami, diagnosed him with tinea corporis, or ringworm, a type of fungal skin infection. During summer, skin problems are more common due to the high temperatures. This is exacerbated by lack of access to clean water to bathe as well as the litter and overflowing sewage in some of the busiest areas.

The medicine used to treat Malek was part of a shipment delivered to 18 clinics and hospitals in Gaza. With access challenges into Gaza and limited health budgets for the clinics, these supplies bring health as well as hope for children like Malek.

To find out more about ANERA's work click here

Malek Harara was treated for a fungal skin infection (Credit ANERA)
Malek Harara was treated for a fungal skin infection (Credit ANERA)

By IHP, Oct 7 2016 01:02PM

International Health Partners (IHP) is urgently calling on its supporters to donate medicines and healthcare supplies, and provide financial support as soon as possible to assist survivors of Hurricane Matthew in Haiti.

“We are extremely grateful to our donors for their ongoing support over the years and are now calling on them to help meet this huge need,” says Adele Paterson, IHP’s Associate Director of Corporate Partnerships.

“Our partners on the ground urgently need essential medicines including antibiotics, analgesics and oral rehydration salts. We would also like to hear about other relevant products that donors might have available at this time,” continues Paterson. “Supporting companies that aren’t able to provide medical support at this time may like to consider making a financial donation to ensure that the medicines reach their destination.”

IHP is seeking to provide Emergency Health Kits and supplies to partners as they assist devastated communities in the aftermath of Hurricane Matthew. Our partners on the ground in Haiti and the Caribbean include International Medical Corps (IMC), Food For The Poor and MedAir.

So far over 300 people have been killed, at least 15,000 people are known to have been displaced and 350,000 people are in need of assistance. Haiti has still not recovered from the 2010 earthquake, with many communities living in tents and less than half the population have access to clean water. The latest assault on the island has caused significant flooding and is highly likely to exacerbate pre-existing epidemics such as cholera, dengue fever.

As with all disasters, needs change on a daily basis. IHP anticipates a second stage of response when assessments are complete and there is more information about specific medical needs beyond the immediate disaster response. Any donated items not used in the appeal will contribute to IHP’s wider medical aid work.

To make a donation click here: https://cafdonate.cafonline.org/5523#/DonationDetails


For more information about how you can help, please contact Adele Paterson at IHP.

Mobile: +44 7833 256949 or email: a.paterson@ihpuk.org

For media enquiries contact IHP Communications Manager Sophia Jones on

Mobile: +44 7802501 698 or email: s.jones@ihpuk.org

By IHP, Sep 22 2015 02:52PM

At IHP, we have watched the news reports of refugees fleeing conflict in the Middle East with great concern and compassion for the people involved. Many of them have endured tremendous hardship in refugee camps for many months or years before setting out on the dangerous journey into Europe.

IHP continues to hold regular conversations with our distributing partners about their need for medicines. At present, we believe that we can be most effective by increasing our support to programmes operating in the countries from which the majority of the refugees begin their journey. The Integral Alliance, of which IHP is a member, note that programmes in these ‘countries of origin’ are chronically underfunded . This significantly increases the incentive for displaced people to make the unsafe and costly journey into Europe.

IHP has excellent working relationships with organisations working in Lebanon and Jordan, hosts to the largest refugee camps. The work done by these organisations is limiting the number of people attempting the journey to Europe and maintaining the possibility of their return home should the current conflicts abate.

Noting the chronically under-funded nature of these programmes, IHP seeks donations of both product and funds. If we can cover the costs of facilitating the shipments of product, we can reach these needy communities much more rapidly. This will help many more families to make the choice to stay where they are, rather than risking their lives, and those of their children, on poorly maintained vessels in the Mediterranean.

Currently, IHP is not intending to respond directly in support of those refugees who have already arrived in Europe. Although numerous, this group is spread across a large geographical area spanning multiple political administrations (many of whom have failed to agree a coherent response strategy). We believe that the medical needs of this group can be met more effectively by the army of local support groups already working with the refugees in their areas. We will, of course, continue to monitor the situation carefully, including keeping a watching brief on any significant needs for consumer hygiene goods, and adjust our approach as necessary.

By IHP, Sep 22 2015 01:51PM

Alex Harris has been appointed as Chief Executive of International Health Partners (IHP). He takes over from Anthony Dunnett CBE, founder of IHP, who led the organisation for 11 years. Alex takes the reins having worked for IHP for 9 years, most recently as VP Operations.

Richard Barker, Chairman of IHP, said “The board are delighted that Alex will be leading IHP through its next phase of growth and development. Alex’s long history with IHP makes him ideally placed to understand the opportunities and challenges facing the organisation and to lead us through the coming years. We are also very grateful for all Anthony has done to bring us to this very exciting point in IHP’s history.”

Anthony Dunnett CBE, the outgoing founder of IHP, said “As I prepare to step down from operational involvement at the end of the year, I’m excited that Alex has agreed to lead IHP into this next stage of its mission to eradicate suffering due to a lack of access to safe medicine. I have worked closely with Alex for many years and he brings to the role many key skills needed to take IHP to the next level and expand our reach across Europe.”

Speaking from the charity’s new offices in Kings Cross, Alex Harris said “When I joined IHP, I never imagined I’d be where I am today, but I’m grateful and humbled to lead the organisation. My passion for improving access to safe medicine is undiminished and I believe that, together with our partners, IHP is well placed to continue meeting the needs of the poor in health”

International Health Partners (IHP) is Europe’s largest coordinator of donated medical products from the healthcare industry to development projects and disaster relief operations. IHP’s Doctors’ Travel Packs (DTP) programme has equipped thousands of travelling doctors to treat over two million people who would otherwise have received no treatment.

In total, IHP has supplied £127 million of medical aid to people in 103 countries, reaching 25 million people. IHP has accepted high-quality donations from over 170 healthcare companies. IHP is regulated by the Medicines and Healthcare Products Regulatory Agency (MHRA) and holds a Wholesale Dealer Authorisation.

By IHP, Jun 3 2015 03:11PM

We are pleased to announce that IHP has joined the Integral Alliance, bringing the Integral membership total to 21 Members with their headquarters in 13 countries.

IHP’s President, Anthny Dunnett says: “We are honoured to join this exciting Alliance of charities seeking to bring a collaborative humanitarian response to natural disasters and conflicts. By working together we can achieve so much more than we could alone. Integral also enables IHP to be part of a holistic response, bringing our expertise in medicine alongside other Members providing, healthcare, shelter, sanitation and economic regeneration. Together we can provide health and hope to those most in need when calamity strikes.”

Andrew Ryskamp, Chair of the Integral Board, says: “Now that IHP is a Member of Integral we are rounding out a dream to have a stronger medical component to our Alliance. We are blessed to benefit not only from the personal gifts Anthony and his staff bring, but also adding the Europe connection to our medically-based membership.”

The Integral Board, made up of the CEO’s and Presidents of Integral Member organisations, unanimously welcomed IHP to membership of Integral at its April 2015 Board meeting in Paris.

By IHP, Mar 23 2015 09:54AM


The charity that matches surplus medicines with acute need

20 March 2015,

International Health Partners cuts waste from aid, writes Andrew Ward

Pharmaceuticals executives might not seem the most likely recipients of hospitality from HRH the Prince of Wales.

The heir to the British throne is well known for his advocacy of homeopathy. Yet, here they are, senior representatives from Pfizer, Johnson & Johnson and many of the world's other big drug makers, sipping champagne in Prince Charles's Clarence House residence in London.

They are here to celebrate the 10th anniversary of a charity, backed by the prince that distributes donated medicines to disaster zones. International Health Partners is not the first organisation to play this role. But its aim is to eliminate inefficiencies that have often undermined relief efforts in the past.

By acting as a brokerage that matches companies' surplus medicines with humanitarian needs, IHP is helping to bring corporate-style supply chain management to international aid.

"In an emergency situation, you don't want 100 different companies all asking the same questions," says Anthony Dunnett, who founded IHP after a career in banking and government. "You want people to be able to see exactly what is needed right away."

The problem IHP is trying to overcome was glaringly visible after the 2004 Indian Ocean tsunami. A multitude of companies and charities rushed to donate 4,000 tonnes of medicines to the region's devastated coastal communities. A year later, a report funded by the World Health Organisation found that half would need to be destroyed because they were out-of-date, inappropriate or simply not needed.

IHP has since tried to avoid this kind of wastage by developing software that allows drug companies to see which products are needed at any given time, based on the requests of aid agencies. The companies, in turn, can use the system to advertise medicines they have available for donation.

"This is not about dumping un-wanted drugs," insists Mr Dunnett." It's about matching need with supply and avoiding duplication. It's a way for companies to work collaboratively on big humanitarian challenges."

While it sounds a simple concept, there are often tricky regulatory obstacles. Companies need assurances that their products will be used in the right way by the right patients in the right place. Donated drugs might leak into a local black market or even be smuggled back to the developed world where they can be sold at a high price.

Mr Dunnett says IHP has avoided this with strict monitoring and by picking its partners carefully. Out of 30m treatments distributed over the past decade, he says only 12 boxes have been lost.

IHP typically receives £15m-£20m worth of medicines each year. These have been directed to more than 100 countries since the charity's inception; war-torn Syria and the storm-hit Philippines have been among its recent priorities.

The charity's reach is set to be increased by a new collaboration called Eurmed involving similar organisations in Germany and Italy. The aim is to build Europe's medical aid capacity into a better match for bigger US relief organisations.

Not everyone in the global health community is a fan of IHP's model. Critics claim that drug donations allow big pharma to feel good about itself while doing nothing to improve long-term access to affordable medicines in the developing world.

Mr Dunnett acknowledges there will always be those who are suspicious of private sector involvement in humanitarian efforts. But he argues that IHP provides a pragmatic way for business to make a positive social contribution. The model could be applied beyond pharmaceuticals, he says, citing food and other consumables as areas where surplus goods could be put to good use.

The Financial Times Limited